today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting taking place March 12-14 ...

New poster to highlight preclinical data of CER-1236 in ovarian cancerSOUTH SAN FRANSCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- CERo ...

Biosciences announced the presentation of preclinical data investigating the potential of co-administration of deoxyribonuclease ...

Immorta Bio Inc., a leader in longevity-focused biotechnologies, announced today acceptance of its poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) Spring Scientific, ...

The poster, titled “Loss of Detectable HPV ... The therapy’s mechanism aims to harness the power of immunotherapy, focusing on inducing robust immune responses to eliminate disease-causing ...

A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer. In findings published in Clinical Cancer Research ...

Scientists reveal that the structure of gut bacteria-derived LPS determines whether cancer immunotherapy succeeds or fails—unlocking a new path to personalized treatments. Analysis: Gut ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...